Market Signal

Amgen Raises Full-Year 2026 Revenue Guidance to Up to $39.4 Billion

Sourced from 1 publication

  • •Amgen raised its 2026 revenue guidance to a range of $38.2 billion to $39.4 billion.
  • •Non-GAAP EPS guidance was set at $22.30 to $23.50 for the full year.
  • •The company is nearing a transition in its CFO position, disclosed alongside the updated guidance.
  • •The Q2 2026 earnings call on August 4 included participation from Investor Relations head Casey Capparelli and other executives.

Sources

Amgen outlines raised 2026 guidance of $38.2B-$39.4B revenue and $22.30-$23.50 n...

Seekingalpha

AGNT, Inc (AGNT) Q2 2026 Earnings Call Transcript

Seekingalpha

Amgen Inc. (AMGN) Q2 2026 Earnings Call Transcript

Seekingalpha

MNTN, Inc. (MNTN) Q2 2026 Earnings Call Transcript

Seekingalpha

Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript

Seekingalpha

Was this story useful?

Curated from 1 sources. Every summary is reviewed for accuracy, but may still contain errors. We always link to original sources for verification.

Related Stories

Spider-Man: Brand New Day Breaks North American Opening Record, Nears $1 Billion Globally

2026-08-04

7.0

China's Manufacturing Sector Slows Amid Weak Demand Indicators

2026-08-03

6.1

Vietnam's Trade Deficit Expands to $3.59 Billion in July Amid Rising Imports

2026-08-03

6.1

About Meridian

Meridian is a free daily newsletter delivering signal-scored news stories with forward-looking analysis every morning. Stories are scored across six criteria (global leverage, capital impact, temporal durability, career relevance, decision utility, and narrative clarity) then assigned to Big Signal, Core, or Quick tiers.

Get Meridian in your inbox

The stories that matter, every morning at 06:00.